Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview

World Journal of Gastroenterology

Volumn 21, Issue 8, 2015, Pages 2269-2280

  Adinolfi, Luigi Elio ^a   Nevola, Riccardo ^a   Lus, Giacomo ^a   Restivo, Luciano ^a   Guerrera, Barbara ^a   Romano, Ciro ^a   Zampino, Rosa ^a   Rinaldi, Luca ^a   Sellitto, Ausilia ^a   Giordano, Mauro ^a   Marrone, Aldo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Hepatitis C virus; Inflammation; Neurological disorders; Psychiatric disorders; Stroke

Indexed keywords

ANTIVIRUS AGENT; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ACUTE DISSEMINATED ENCEPHALOMYELITIS; ANTIVIRAL THERAPY; ANXIETY DISORDER; BRAIN ISCHEMIA; CAROTID ATHEROSCLEROSIS; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; CRYOGLOBULINEMIA; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; ENCEPHALOMYELITIS; EXECUTIVE FUNCTION; HEPATITIS C; HUMAN; MAJOR DEPRESSION; MENINGITIS; MENTAL DISEASE; METABOLIC REGULATION; MYELITIS; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NEUROTOXICITY; OCCLUSIVE CEREBROVASCULAR DISEASE; PATHOPHYSIOLOGY; PERIPHERAL NEUROPATHY; REVIEW; ANIMAL; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; COMPLICATION; DRUG EFFECTS; HEPACIVIRUS; HEPATITIS C, CHRONIC; MENTAL DISORDERS; PATHOGENICITY; PSYCHOLOGY; TREATMENT OUTCOME; VIROLOGY;

ANIMALS; ANTIVIRAL AGENTS; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM VIRAL DISEASES; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MENTAL DISORDERS; TREATMENT OUTCOME;

EID: 84923795457     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v21.i8.2269     Document Type: Review

References (153)

1. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of agespecific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342 [PMID: 23172780 DOI: 10.1002/hep.26141]
2. Zignego AL, Craxì A. Extrahepatic manifestations of hepatitis C virus infection. Clin Liver Dis 2008; 12: 611-36, ix [PMID: 18625431 DOI: 10.1016/j.cld.2008.03.012]
3. Adinolfi LE, Restivo L, Zampino R, Lonardo A, Loria P. Metabolic alterations and chronic hepatitis C: treatment strategies. Expert Opin Pharmacother 2011; 12: 2215-2234 [PMID: 21883025 DOI: 10.1517/14656566.2011.597742]
4. Adinolfi LE, Zampino R, Restivo L, Lonardo A, Guerrera B, Marrone A, Nascimbeni F, Florio A, Loria P. Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms. World J Gastroenterol 2014; 20: 3410-3417 [PMID: 24707124 DOI: 10.3748/wjg.v20.i13.3410]
5. Durante-Mangoni E, Iardino P, Resse M, Cesaro G, Sica A, Farzati B, Ruggiero G, Adinolfi LE. Silent celiac disease in chronic hepatitis C: impact of interferon treatment on the disease onset and clinical outcome. J Clin Gastroenterol 2004; 38: 901-905 [PMID: 15492610]
6. Johnson RJ, Gretch DR, Yamabe H, Hart J, Bacchi CE, Hartwell P, Couser WG, Corey L, Wener MH, Alpers CE. Membranoproliferative glomerulonephritis associated with hepatitis C virus infection. N Engl J Med 1993; 328: 465-470 [PMID: 7678440]
7. Antonelli A, Ferri C, Pampana A, Fallahi P, Nesti C, Pasquini M, Marchi S, Ferrannini E. Thyroid disorders in chronic hepatitis C. Am J Med 2004; 117: 10-13 [PMID: 15210382]
8. Féray C. Is HCV infection a neurologic disorder? Gastroenterology 2012; 142: 428-431 [PMID: 22285362 DOI: 10.1053/j.gastro.2012.01.010]
9. Adinolfi LE, Utili R, Attanasio V, Zampino R, Ragone E, Tripodi MF, Ruggiero G. Epidemiology, clinical spectrum and prognostic value of mixed cryoglobulinaemia in hepatitis C virus patients: a prospective study. Ital J Gastroenterol 1996; 28: 1-9 [PMID: 8743066]
10. Nagao Y, Sata M. Hepatitis C virus and lichen planus. J Gastroenterol Hepatol 2004; 19: 1101-1113 [PMID: 15377286 DOI: 10.1046/j.1440-1746.2003.03324.x]
11. Revie D, Salahuddin SZ. Human cell types important for hepatitis C virus replication in vivo and in vitro: old assertions and current evidence. Virol J 2011; 8: 346 [PMID: 21745397 DOI: 10.1186/1743-422X-8-346]
12. Zampino R, Marrone A, Restivo L, Guerrera B, Sellitto A, Rinaldi L, Romano C, Adinolfi LE. Chronic HCV infection and inflammation: Clinical impact on hepatic and extra-hepatic manifestations. World J Hepatol 2013; 5: 528-540 [PMID: 24179612 DOI: 10.4254/wjh.v5.i10.528]
13. Monaco S, Ferrari S, Gajofatto A, Zanusso G, Mariotto S. HCVrelated nervous system disorders. Clin Dev Immunol 2012; 2012: 236148 [PMID: 22899946 DOI: 10.1155/2012/236148]
14. Origgi L, Vanoli M, Carbone A, Grasso M, Scorza R. Central nervous system involvement in patients with HCV-related cryoglobulinemia. Am J Med Sci 1998; 315: 208-210 [PMID: 9519936]
15. Fletcher NF, McKeating JA. Hepatitis C virus and the brain. J Viral Hepat 2012; 19: 301-306 [PMID: 22497808 DOI: 10.1111/j.1365-2893.2012.01591.x]
16. Radkowski M, Wilkinson J, Nowicki M, Adair D, Vargas H, Ingui C, Rakela J, Laskus T. Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication. J Virol 2002; 76: 600-608 [PMID: 11752151]
17. Forton DM, Karayiannis P, Mahmud N, Taylor-Robinson SD, Thomas HC. Identification of unique hepatitis C virus quasispecies in the central nervous system and comparative analysis of internal translational efficiency of brain, liver, and serum variants. J Virol 2004; 78: 5170-5183 [PMID: 15113899]
18. Adinolfi LE, Restivo L, Guerrera B, Sellitto A, Ciervo A, Iuliano N, Rinaldi L, Santoro A, Li Vigni G, Marrone A. Chronic HCV infection is a risk factor of ischemic stroke. Atherosclerosis 2013; 231: 22-26 [PMID: 24125405 DOI: 10.1016/j.atherosclerosis.2013.08.003]
19. Petty GW, Duffy J, Houston J. Cerebral ischemia in patients with hepatitis C virus infection and mixed cryoglobulinemia. Mayo Clin Proc 1996; 71: 671-678 [PMID: 8656709]
20. Cacoub P, Sbaï A, Hausfater P, Papo T, Gatel A, Piette JC. [Central nervous system involvement in hepatitis C virus infection]. Gastroenterol Clin Biol 1998; 22: 631-633 [PMID: 9762334]
21. Enger C, Forssen UM, Bennett D, Theodore D, Shantakumar S, McAfee A. Thromboembolic events among patients with hepatitis C virus infection and cirrhosis: a matched-cohort study. Adv Ther 2014; 31: 891-903 [PMID: 25047758 DOI: 10.1007/s12325-014-0138-4]
22. Gutierrez J, Elkind MSV. Chronic inflammatory diseases and stroke: Evidence for heterogeneous mechanisms. Ann Neurol 2012; 72: S6-S7
23. Liao CC, Su TC, Sung FC, Chou WH, Chen TL. Does hepatitis C virus infection increase risk for stroke? A population-based cohort study. PLoS One 2012; 7: e31527 [PMID: 22363662 DOI: 10.1371/journal.pone.0031527]
24. Hsu CS, Kao JH, Chao YC, Lin HH, Fan YC, Huang CJ, Tsai PS. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. Aliment Pharmacol Ther 2013; 38: 415-423 [PMID: 23802888 DOI: 10.1111/apt.12391]
25. Younossi ZM, Stepanova M, Nader F, Younossi Z, Elsheikh E. Associations of chronic hepatitis C with metabolic and cardiac outcomes. Aliment Pharmacol Ther 2013; 37: 647-652 [PMID: 23384408 DOI: 10.1111/apt.12234]
26. He Huang R, Zhao Z. Hepatitis C virus infection and risk of stroke: a systematic review and meta-analysis. PLoS One 2013; 8: e81305 [PMID: 24265844 DOI: 10.1371/journal.pone.0081305]
27. Lee MH, Yang HI, Wang CH, Jen CL, Yeh SH, Liu CJ, You SL, Chen WJ, Chen CJ. Hepatitis C virus infection and increased risk of cerebrovascular disease. Stroke 2010; 41: 2894-2900 [PMID: 20966408 DOI: 10.1161/STROKEAHA.110.598136]
28. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 2002; 105: 1135-1143 [PMID: 11877368]
29. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke 2006; 37: 1923-1932 [PMID: 16741184]
30. Adinolfi LE, Restivo L, Zampino R, Guerrera B, Lonardo A, Ruggiero L, Riello F, Loria P, Florio A. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis. Atherosclerosis 2012; 221: 496-502 [PMID: 22385985 DOI: 10.1016/j.atherosclerosis.2012.01.051]
31. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med 2005; 352: 1685-1695 [PMID: 15843671]
32. Ishizaka N, Ishizaka Y, Takahashi E, Tooda Ei, Hashimoto H, Nagai R, Yamakado M. Association between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickening. Lancet 2002; 359: 133-135 [PMID: 11809259]
33. Aslam F, Alam M, Lakkis NM. Hepatitis C and carotid atherosclerosis: a retrospective analysis. Atherosclerosis 2010; 209: 340-343 [PMID: 19883912 DOI: 10.1016/j.atherosclerosis.2009.10.006]
34. Fukui M, Kitagawa Y, Nakamura N, Yoshikawa T. Hepatitis C virus and atherosclerosis in patients with type 2 diabetes. JAMA 2003; 289: 1245-1246 [PMID: 12633185]
35. Boddi M, Abbate R, Chellini B, Giusti B, Giannini C, Pratesi G, Rossi L, Pratesi C, Gensini GF, Paperetti L, Zignego AL. Hepatitis C virus RNA localization in human carotid plaques. J Clin Virol 2010; 47: 72-75 [PMID: 19896417 DOI: 10.1016/j.jcv.2009.10.005]
36. Okuda M, Li K, Beard MR, Showalter LA, Scholle F, Lemon SM, Weinman SA. Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein. Gastroenterology 2002; 122: 366-375 [PMID: 11832451]
37. Vidali M, Tripodi MF, Ivaldi A, Zampino R, Occhino G, Restivo L, Sutti S, Marrone A, Ruggiero G, Albano E, Adinolfi LE. Interplay between oxidative stress and hepatic steatosis in the progression of chronic hepatitis C. J Hepatol 2008; 48: 399-406 [PMID: 18164507 DOI: 10.1016/j.jhep.2007.10.011]
38. Heckmann JG, Kayser C, Heuss D, Manger B, Blum HE, Neundörfer B. Neurological manifestations of chronic hepatitis C. J Neurol 1999; 246: 486-491 [PMID: 10431776]
39. Dawson TM, Starkebaum G. Isolated central nervous system vasculitis associated with hepatitis C infection. J Rheumatol 1999; 26: 2273-2276 [PMID: 10529155]
40. Arena MG, Ferlazzo E, Bonanno D, Quattrocchi P, Ferlazzo B. Cerebral vasculitis in a patient with HCV-related type II mixed cryoglobulinemia. J Investig Allergol Clin Immunol 2003; 13: 135-136 [PMID: 12968400]
41. Castro Caldas A, Geraldes R, Neto L, Canhão P, Melo TP. Central nervous system vasculitis associated with hepatitis C virus infection: a brain MRI-supported diagnosis. J Neurol Sci 2014; 336: 152-154 [PMID: 24211061 DOI: 10.1016/j.jns.2013.10.028]
42. Malnick SD, Abend Y, Evron E, Sthoeger ZM. HCV hepatitis associated with anticardiolipin antibody and a cerebrovascular accident. Response to interferon therapy. J Clin Gastroenterol 1997; 24: 40-42 [PMID: 9013350]
43. Cojocaru IM, Cojocaru M, Iacob SA. High prevalence of anticardiolipin antibodies in patients with asymptomatic hepatitis C virus infection associated acute ischemic stroke. Rom J Intern Med 2005; 43: 89-95 [PMID: 16739869]
44. Cojocaru IM, Cojocaru M, Burcin C. Ischemic stroke accompanied by anti-PR3 antibody-related cerebral vasculitis and hepatitis C virus infection. Rom J Intern Med 2007; 45: 47-50 [PMID: 17966442]
45. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis 2005; 5: 227-236 [PMID: 15792740]
46. Serena M, Biscaro R, Moretto G, Recchia E. Peripheral and central nervous system involvement in essential mixed cryoglobulinemia: a case report. Clin Neuropathol 1991; 10: 177-180 [PMID: 1884525]
47. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008; 49: 831-844 [PMID: 18814931 DOI: 10.1016/j.jhep.2008.08.006]
48. Lonardo A, Adinolfi LE, Petta S, Craxì A, Loria P. Hepatitis C and diabetes: the inevitable coincidence? Expert Rev Anti Infect Ther 2009; 7: 293-308 [PMID: 19344243 DOI: 10.1586/eri.09.3]
49. Fletcher NF, Wilson GK, Murray J, Hu K, Lewis A, Reynolds GM, Stamataki Z, Meredith LW, Rowe IA, Luo G, Lopez-Ramirez MA, Baumert TF, Weksler B, Couraud PO, Kim KS, Romero IA, Jopling C, Morgello S, Balfe P, McKeating JA. Hepatitis C virus infects the endothelial cells of the blood-brain barrier. Gastroenterology 2012; 142: 634-643.e6 [PMID: 22138189 DOI: 10.1053/j.gastro.2011.11.028]
50. Seifert F, Struffert T, Hildebrandt M, Blümcke I, Brück W, Staykov D, Huttner HB, Hilz MJ, Schwab S, Bardutzky J. In vivo detection of hepatitis C virus (HCV) RNA in the brain in a case of encephalitis: evidence for HCV neuroinvasion. Eur J Neurol 2008; 15: 214-218 [PMID: 18215154 DOI: 10.1111/j.1468-1331.2007.02044.x]
51. Bolay H, Söylemezoğlu F, Nurlu G, Tuncer S, Varli K. PCR detected hepatitis C virus genome in the brain of a case with progressive encephalomyelitis with rigidity. Clin Neurol Neurosurg 1996; 98: 305-308 [PMID: 9081776]
52. Grewal AK, Lopes MB, Berg CL, Bennett AK, Alves VA, Trugman JM. Recurrent demyelinating myelitis associated with hepatitis C viral infection. J Neurol Sci 2004; 224: 101-106 [PMID: 15450779]
53. Zandman-Goddard G, Levy Y, Weiss P, Shoenfeld Y, Langevitz P. Transverse myelitis associated with chronic hepatitis C. Clin Exp Rheumatol 2003; 21: 111-113 [PMID: 12673901]
54. De Carli DM, Pannebeker J, Pedro FL, Haygert CJ, Hertz E, Beck Mde O. Transverse myelitis associated to HCV infection. Braz J Infect Dis 2009; 13: 147-152 [PMID: 20140361]
55. Aktipi KM, Ravaglia S, Ceroni M, Nemni R, Debiaggi M, Bastianello S, Alfonsi E, Zardini E, Minoli L, Tavazzi E, Marchioni E. Severe recurrent myelitis in patients with hepatitis C virus infection. Neurology 2007; 68: 468-469 [PMID: 17283325]
56. Sacconi S, Salviati L, Merelli E. Acute disseminated encephalomyelitis associated with hepatitis C virus infection. Arch Neurol 2001; 58: 1679-1681 [PMID: 11594929]
57. Sim JE, Lee JB, Cho YN, Suh SH, Kim JK, Lee KY. A case of acute disseminated encephalomyelitis associated with hepatitis C virus infection. Yonsei Med J 2012; 53: 856-858 [PMID: 22665357 DOI: 10.3349/ymj.2012.53.4.856]
58. Forton DM, Thomas HC, Murphy CA, Allsop JM, Foster GR, Main J, Wesnes KA, Taylor-Robinson SD. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35: 433-439 [PMID: 11826420]
59. Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35: 440-446 [PMID: 11826421]
60. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003; 9: 847-854 [PMID: 14632243]
61. Kramer L, Bauer E, Funk G, Hofer H, Jessner W, Steindl-Munda P, Wrba F, Madl C, Gangl A, Ferenci P. Subclinical impairment of brain function in chronic hepatitis C infection. J Hepatol 2002; 37: 349-354 [PMID: 12175630]
62. Bieliauskas LA, Back-Madruga C, Lindsay KL, Wright EC, Kronfol Z, Lok AS, Fontana RJ. Cognitive reserve and neuropsychological functioning in patients infected with hepatitis C. J Int Neuropsychol Soc 2007; 13: 687-692 [PMID: 17521478]
63. Cherner M, Letendre S, Heaton RK, Durelle J, Marquie-Beck J, Gragg B, Grant I. Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology 2005; 64: 1343-1347 [PMID: 15851720]
64. McAndrews MP, Farcnik K, Carlen P, Damyanovich A, Mrkonjic M, Jones S, Heathcote EJ. Prevalence and significance of neurocognitive dysfunction in hepatitis C in the absence of correlated risk factors. Hepatology 2005; 41: 801-808 [PMID: 15793853 DOI: 10.1002/hep.20635]
65. Córdoba J, Flavià M, Jacas C, Sauleda S, Esteban JI, Vargas V, Esteban R, Guardia J. Quality of life and cognitive function in hepatitis C at different stages of liver disease. J Hepatol 2003; 39: 231-238 [PMID: 12873820]
66. Martin EM, Novak RM, Fendrich M, Vassileva J, Gonzalez R, Grbesic S, Nunnally G, Sworowski L. Stroop performance in drug users classified by HIV and hepatitis C virus serostatus. J Int Neuropsychol Soc 2004; 10: 298-300 [PMID: 15012850]
67. Fontana RJ, Bieliauskas LA, Back-Madruga C, Lindsay KL, Kronfol Z, Lok AS, Padmanabhan L. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 2005; 43: 614-622 [PMID: 16237784]
68. Chiu WC, Tsan YT, Tsai SL, Chang CJ, Wang JD, Chen PC. Hepatitis C viral infection and the risk of dementia. Eur J Neurol 2014; 21: 1068-1e59 [PMID: 24313931 DOI: 10.1111/ene.12317]
69. Abrantes J, Torres DS, de Mello CE. Patients with hepatitis C infection and normal liver function: an evaluation of cognitive function. Postgrad Med J 2013; 89: 433-439 [PMID: 23625064 DOI: 10.1136/postgradmedj-2012-121185]
70. Bonetti B, Scardoni M, Monaco S, Rizzuto N, Scarpa A. Hepatitis C virus infection of peripheral nerves in type II cryoglobulinaemia. Virchows Arch 1999; 434: 533-535 [PMID: 10394889]
71. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, Yamamoto AM, Camproux AC, Hausfater P, Musset L, Veyssier P, Raguin G, Piette JC. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine (Baltimore) 2000; 79: 47-56 [PMID: 10670409]
72. Zaltron S, Puoti M, Liberini P, Antonini L, Quinzanini M, Manni M, Forleo MA, Rossi S, Spinetti A, Zanini B, Carosi G. High prevalence of peripheral neuropathy in hepatitis C virus infected patients with symptomatic and asymptomatic cryoglobulinaemia. Ital J Gastroenterol Hepatol 1998; 30: 391-395 [PMID: 9789135]
73. Migliaresi S, Di Iorio G, Ammendola A, Ambrosone L, Sanges G, Ugolini G, Sampaolo S, Bravaccio F, Tirri G. [Peripheral nervous system involvement in HCV-related mixed cryoglobulinemia] Reumatismo 2001; 53: 26-32 [PMID: 12461575]
74. Vital C, Vital A, Canron MH, Jaffré A, Viallard JF, Ragnaud JM, Brechenmacher C, Lagueny A. Combined nerve and muscle biopsy in the diagnosis of vasculitic neuropathy. A 16-year retrospective study of 202 cases. J Peripher Nerv Syst 2006; 11: 20-29 [PMID: 16519779]
75. Gemignani F, Melli G, Inglese C, Marbini A. Cryoglobulinemia is a frequent cause of peripheral neuropathy in undiagnosed referral patients. J Peripher Nerv Syst 2002; 7: 59-64 [PMID: 11939353]
76. Gemignani F, Brindani F, Alfieri S, Giuberti T, Allegri I, Ferrari C, Marbini A. Clinical spectrum of cryoglobulinaemic neuropathy. J Neurol Neurosurg Psychiatry 2005; 76: 1410-1414 [PMID: 16170087]
77. Herrmann DN, Ferguson ML, Pannoni V, Barbano RL, Stanton M, Logigian EL. Plantar nerve AP and skin biopsy in sensory neuropathies with normal routine conduction studies. Neurology 2004; 63: 879-885 [PMID: 15365140]
78. Gemignani F, Marbini A. Restless legs syndrome and peripheral neuropathy. J Neurol Neurosurg Psychiatry 2002; 72: 555 [PMID: 11909928]
79. Tembl JI, Ferrer JM, Sevilla MT, Lago A, Mayordomo F, Vilchez JJ. Neurologic complications associated with hepatitis C virus infection. Neurology 1999; 53: 861-864 [PMID: 10489056]
80. Bant A, Hurowitz B, Hassan N, Du VT, Nadir A. Complex regional pain syndrome (reflex sympathetic dystrophy) in a patient with essential mixed cryoglobulinemia and chronic hepatitis C. J Pak Med Assoc 2007; 57: 96-98 [PMID: 17370795]
81. Nemni R, Corbo M, Fazio R, Quattrini A, Comi G, Canal N. Cryoglobulinaemic neuropathy. A clinical, morphological and immunocytochemical study of 8 cases. Brain 1988; 111 (Pt 3): 541-552 [PMID: 2838123]
82. Chad D, Pariser K, Bradley WG, Adelman LS, Pinn VW. The pathogenesis of cryoglobulinemic neuropathy. Neurology 1982; 32: 725-729 [PMID: 6283424]
83. Dyck PJ, Benstead TJ, Conn DL, Stevens JC, Windebank AJ, Low PA. Nonsystemic vasculitic neuropathy. Brain 1987; 110 (Pt 4): 843-853 [PMID: 3651797]
84. Nemni R, Sanvito L, Quattrini A, Santuccio G, Camerlingo M, Canal N. Peripheral neuropathy in hepatitis C virus infection with and without cryoglobulinaemia. J Neurol Neurosurg Psychiatry 2003; 74: 1267-1271 [PMID: 12933932]
85. Bonetti B, Invernizzi F, Rizzuto N, Bonazzi ML, Zanusso GL, Chinaglia G, Monaco S. T-cell-mediated epineurial vasculitis and humoral-mediated microangiopathy in cryoglobulinemic neuropathy. J Neuroimmunol 1997; 73: 145-154 [PMID: 9058770]
86. Authier FJ, Bassez G, Payan C, Guillevin L, Pawlotsky JM, Degos JD, Gherardi RK, Belec L. Detection of genomic viral RNA in nerve and muscle of patients with HCV neuropathy. Neurology 2003; 60: 808-812 [PMID: 12629238]
87. Younis LK, Talaat FM, Deif AH, Borei MF, Reheim SM, El Salmawy DH. Immunohistochemical detection of HCV in nerves and muscles of patients with HCV associated peripheral neuropathy and myositis. Int J Health Sci (Qassim) 2007; 1: 195-202 [PMID: 21475428]
88. Paoletti V, Donnarumma L, De Matteis A, Mammarella A, Labbadia G, Musca A, Francia A. Peripheral neuropathy without cryoglobulinemia in patients with hepatitis C virus infection. Panminerva Med 2000; 42: 175-178 [PMID: 11218620]
89. Lidove O, Cacoub P, Maisonobe T, Servan J, Thibault V, Piette JC, Léger JM. Hepatitis C virus infection with peripheral neuropathy is not always associated with cryoglobulinaemia. Ann Rheum Dis 2001; 60: 290-292 [PMID: 11171696]
90. Bonetti B, Monaco S, Giannini C, Ferrari S, Zanusso G, Rizzuto N. Human peripheral nerve macrophages in normal and pathological conditions. J Neurol Sci 1993; 118: 158-168 [PMID: 8229064]
91. De Martino L, Sampaolo S, Tucci C, Ambrosone L, Budillon A, Migliaresi S, Di Iorio G. Viral RNA in nerve tissues of patients with hepatitis C infection and peripheral neuropathy. Muscle Nerve 2003; 27: 102-104 [PMID: 12508302]
92. Gemignani F, Pavesi G, Fiocchi A, Manganelli P, Ferraccioli G, Marbini A. Peripheral neuropathy in essential mixed cryoglobulinaemia. J Neurol Neurosurg Psychiatry 1992; 55: 116-120 [PMID: 1311372]
93. Costa J, Resende C, de Carvalho M. Motor-axonal polyneuropathy associated with hepatitis C virus. Eur J Neurol 2003; 10: 183-185 [PMID: 12603295]
94. Ammendola A, Sampaolo S, Migliaresi S, Ambrosone L, Ammendola E, Ciccone G, Di Iorio G. Autonomic neuropathy in mixed cryoglobulinemia. J Neurol 2007; 254: 215-219 [PMID: 17334955]
95. Lippa CF, Chad DA, Smith TW, Kaplan MH, Hammer K. Neuropathy associated with cryoglobulinemia. Muscle Nerve 1986; 9: 626-631 [PMID: 3020402]
96. Caporale CM, Capasso M, Ragno M, Di Muzio A, Uncini A. Lewis-Sumner syndrome in hepatitis C virus infection: a possible pathogenetic association with therapeutic problems. Muscle Nerve 2006; 34: 116-121 [PMID: 16453326]
97. Boukhris S, Magy L, Senga-mokono U, Loustaud-ratti V, Vallat JM. Polyneuropathy with demyelinating features in mixed cryoglobulinemia with hepatitis C virus infection. Eur J Neurol 2006; 13: 937-941 [PMID: 16930357]
98. Bezerra ML, Harumi JA, Shinosaki JS, Pedroso JL, Henriques de Aquino CC, de Souza LT, Baiense RF, Bulle de Oliveira AS. Hepatitis C virus: a rare manifestation--remitting relapsing central and peripheral demyelination. Neurol India 2011; 59: 114-116 [PMID: 21339677 DOI: 10.4103/0028-3886.76889]
99. Tillmann HL. Hepatitis C virus infection and the brain. Metab Brain Dis 2004; 19: 351-356 [PMID: 15554427]
100. Goh J, Coughlan B, Quinn J, O’Keane JC, Crowe J. Fatigue does not correlate with the degree of hepatitis or the presence of autoimmune disorders in chronic hepatitis C infection. Eur J Gastroenterol Hepatol 1999; 11: 833-838 [PMID: 10514113]
101. Foster GR, Goldin RD, Thomas HC. Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis. Hepatology 1998; 27: 209-212 [PMID: 9425939]
102. Amodio P, Salari L, Montagnese S, Schiff S, Neri D, Bianco T, Minazzato L. Hepatitis C virus infection and health-related quality of life. World J Gastroenterol 2012; 18: 2295-2299 [PMID: 22654420 DOI: 10.3748/wjg.v18.i19.2295]
103. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL. Assessing health-related quality of life in chronic hepatitis C using the Sickness Impact Profile. Clin Ther 1994; 16: 334-43; discussion 271-2 [PMID: 8062327]
104. Ware JE, Bayliss MS, Mannocchia M, Davis GL. Healthrelated quality of life in chronic hepatitis C: impact of disease and treatment response. The Interventional Therapy Group. Hepatology 1999; 30: 550-555 [PMID: 10421667]
105. Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. The Consensus Interferon Study Group. Hepatology 1999; 29: 264-270 [PMID: 9862876]
106. Carithers RL, Sugano D, Bayliss M. Health assessment for chronic HCV infection: results of quality of life. Dig Dis Sci 1996; 41: 75S-80S [PMID: 9011480]
107. Rodger AJ, Jolley D, Thompson SC, Lanigan A, Crofts N. The impact of diagnosis of hepatitis C virus on quality of life. Hepatology 1999; 30: 1299-1301 [PMID: 10534353]
108. Córdoba J, Reyes J, Esteban JI, Hernández JM. Labeling may be an important cause of reduced quality of life in chronic hepatitis C. Am J Gastroenterol 2003; 98: 226-227 [PMID: 12526976]
109. Schwarzinger M, Dewedar S, Rekacewicz C, Abd Elaziz KM, Fontanet A, Carrat F, Mohamed MK. Chronic hepatitis C virus infection: does it really impact health-related quality of life? A study in rural Egypt. Hepatology 2004; 40: 1434-1441 [PMID: 15565610]
110. Miller ER, McNally S, Wallace J, Schlichthorst M. The ongoing impacts of hepatitis c--a systematic narrative review of the literature. BMC Public Health 2012; 12: 672 [PMID: 22900973 DOI: 10.1186/1471-2458-12-672]
111. Ashrafi M, Modabbernia A, Dalir M, Taslimi S, Karami M, Ostovaneh MR, Malekzadeh R, Poustchi H. Predictors of mental and physical health in non-cirrhotic patients with viral hepatitis: a case control study. J Psychosom Res 2012; 73: 218-224 [PMID: 22850263 DOI: 10.1016/j.jpsychores.2012.06.006]
112. Modabbernia A, Ashrafi M, Keyvani H, Taslimi S, Poorkaveh A, Merat S, Poustchi H, Malekzadeh R. Brain-derived neurotrophic factor predicts physical health in untreated patients with hepatitis C. Biol Psychiatry 2011; 70: e31-e32 [PMID: 21429476 DOI: 10.1016/j.biopsych.2011.01.028]
113. Sockalingam S, Abbey SE, Alosaimi F, Novak M. A review of sleep disturbance in hepatitis C. J Clin Gastroenterol 2010; 44: 38-45 [PMID: 19730115 DOI: 10.1097/MCG.0b013e3181b314ea]
114. Hilsabeck RC, Hassanein TI, Perry W. Biopsychosocial predictors of fatigue in chronic hepatitis C. J Psychosom Res 2005; 58: 173-178 [PMID: 15820845]
115. Carta MG, Angst J, Moro MF, Mura G, Hardoy MC, Balestrieri C, Chessa L, Serra G, Lai ME, Farci P. Association of chronic hepatitis C with recurrent brief depression. J Affect Disord 2012; 141: 361-366 [PMID: 22609196 DOI: 10.1016/j.jad.2012.03.020]
116. Navinés R, Castellví P, Moreno-España J, Gimenez D, Udina M, Cañizares S, Diez-Quevedo C, Valdés M, Solà R, Martín-Santos R. Depressive and anxiety disorders in chronic hepatitis C patients: reliability and validity of the Patient Health Questionnaire. J Affect Disord 2012; 138: 343-351 [PMID: 22326842 DOI: 10.1016/j.jad.2012.01.018]
117. Evon DM, Simpson KM, Esserman D, Verma A, Smith S, Fried MW. Barriers to accessing care in patients with chronic hepatitis C: the impact of depression. Aliment Pharmacol Ther 2010; 32: 1163-1173 [PMID: 21039678 DOI: 10.1111/j.1365-2036.2010.04460.x]
118. Adinolfi LE, Andreana A, Utili R, Zampino R, Ragone E, Ruggiero G. HCV RNA levels in serum, liver, and peripheral blood mononuclear cells of chronic hepatitis C patients and their relationship to liver injury. Am J Gastroenterol 1998; 93: 2162-2166 [PMID: 9820390]
119. Letendre S, Paulino AD, Rockenstein E, Adame A, Crews L, Cherner M, Heaton R, Ellis R, Everall IP, Grant I, Masliah E. Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV. J Infect Dis 2007; 196: 361-370 [PMID: 17597450]
120. Fishman SL, Murray JM, Eng FJ, Walewski JL, Morgello S, Branch AD. Molecular and bioinformatic evidence of hepatitis C virus evolution in brain. J Infect Dis 2008; 197: 597-607 [PMID: 18275278 DOI: 10.1086/526519]
121. Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J. Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation. Liver Transpl 2002; 8: 1014-1019 [PMID: 12424714]
122. Wilkinson J, Radkowski M, Laskus T. Hepatitis C virus neuroinvasion: identification of infected cells. J Virol 2009; 83: 1312-1319 [PMID: 19019968 DOI: 10.1128/JVI.01890-08]
123. Bednarska A, Horban A, Radkowski M. Central nervous system as a possible site of HCV replication. Przegl Epidemiol 2007; 61: 739-745 [PMID: 18572506]
124. Senzolo M, Schiff S, D’Aloiso CM, Crivellin C, Cholongitas E, Burra P, Montagnese S. Neuropsychological alterations in hepatitis C infection: the role of inflammation. World J Gastroenterol 2011; 17: 3369-3374 [PMID: 21876628 DOI: 10.3748/wjg.v17.i29.3369]
125. Laskus T, Radkowski M, Adair DM, Wilkinson J, Scheck AC, Rakela J. Emerging evidence of hepatitis C virus neuroinvasion. AIDS 2005; 19 Suppl 3: S140-S144 [PMID: 16251811]
126. Wilkinson J, Radkowski M, Eschbacher JM, Laskus T. Activation of brain macrophages/microglia cells in hepatitis C infection. Gut 2010; 59: 1394-1400 [PMID: 20675697 DOI: 10.1136/gut.2009.199356]
127. Vivithanaporn P, Maingat F, Lin LT, Na H, Richardson CD, Agrawal B, Cohen EA, Jhamandas JH, Power C. Hepatitis C virus core protein induces neuroimmune activation and potentiates Human Immunodeficiency Virus-1 neurotoxicity. PLoS One 2010; 5: e12856 [PMID: 20877724 DOI: 10.1371/journal.pone.0012856]
128. Paulino AD, Ubhi K, Rockenstein E, Adame A, Crews L, Letendre S, Ellis R, Everall IP, Grant I, Masliah E. Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling. J Neurovirol 2011; 17: 327-340 [PMID: 21660601 DOI: 10.1007/s13365-011-0039-0]
129. Murray J, Fishman SL, Ryan E, Eng FJ, Walewski JL, Branch AD, Morgello S. Clinicopathologic correlates of hepatitis C virus in brain: a pilot study. J Neurovirol 2008; 14: 17-27 [PMID: 18300072 DOI: 10.1080/13550280701708427]
130. Weissenborn K, Krause J, Bokemeyer M, Hecker H, Schüler A, Ennen JC, Ahl B, Manns MP, Böker KW. Hepatitis C virus infection affects the brain-evidence from psychometric studies and magnetic resonance spectroscopy. J Hepatol 2004; 41: 845-851 [PMID: 15519659]
131. Forton DM, Allsop JM, Main J, Foster GR, Thomas HC, Taylor-Robinson SD. Evidence for a cerebral effect of the hepatitis C virus. Lancet 2001; 358: 38-39 [PMID: 11454379]
132. Taylor-Robinson SD, Buckley C, Changani KK, Hodgson HJ, Bell JD. Cerebral proton and phosphorus-31 magnetic resonance spectroscopy in patients with subclinical hepatic encephalopathy. Liver 1999; 19: 389-398 [PMID: 10533796]
133. Chaudhuri A, Behan PO. In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids 2004; 71: 181-183 [PMID: 15253888]
134. Ernst T, Chang L. Effect of aging on brain metabolism in antiretroviral-naive HIV patients. AIDS 2004; 18 Suppl 1: S61-S67 [PMID: 15075499]
135. Bokemeyer M, Ding XQ, Goldbecker A, Raab P, Heeren M, Arvanitis D, Tillmann HL, Lanfermann H, Weissenborn K. Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy. Gut 2011; 60: 370-377 [PMID: 20926642 DOI: 10.1136/gut.2010.217976]
136. Piche T, Vanbiervliet G, Cherikh F, Antoun Z, Huet PM, Gelsi E, Demarquay JF, Caroli-Bosc FX, Benzaken S, Rigault MC, Renou C, Rampal P, Tran A. Effect of ondansetron, a 5-HT3 receptor antagonist, on fatigue in chronic hepatitis C: a randomised, double blind, placebo controlled study. Gut 2005; 54: 1169-1173 [PMID: 16009690]
137. Cozzi A, Zignego AL, Carpendo R, Biagiotti T, Aldinucci A, Monti M, Giannini C, Rosselli M, Laffi G, Moroni F. Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patients. J Viral Hepat 2006; 13: 402-408 [PMID: 16842443]
138. Weissenborn K, Ennen JC, Bokemeyer M, Ahl B, Wurster U, Tillmann H, Trebst C, Hecker H, Berding G. Monoaminergic neurotransmission is altered in hepatitis C virus infected patients with chronic fatigue and cognitive impairment. Gut 2006; 55: 1624-1630 [PMID: 16682431]
139. Heeren M, Weissenborn K, Arvanitis D, Bokemeyer M, Goldbecker A, Tountopoulou A, Peschel T, Grosskreutz J, Hecker H, Buchert R, Berding G. Cerebral glucose utilisation in hepatitis C virus infection-associated encephalopathy. J Cereb Blood Flow Metab 2011; 31: 2199-2208 [PMID: 21629258 DOI: 10.1038/jcbfm.2011.82]
140. Huckans M, Fuller BE, Olavarria H, Sasaki AW, Chang M, Flora KD, Kolessar M, Kriz D, Anderson JR, Vandenbark AA, Loftis JM. Multi-analyte profile analysis of plasma immune proteins: altered expression of peripheral immune factors is associated with neuropsychiatric symptom severity in adults with and without chronic hepatitis C virus infection. Brain Behav 2014; 4: 123-142 [PMID: 24683507 DOI: 10.1002/brb3.200]
141. Capuron L, Miller AH. Cytokines and psychopathology: lessons from interferon-alpha. Biol Psychiatry 2004; 56: 819-824 [PMID: 15576057]
142. Capuron L, Pagnoni G, Demetrashvili M, Woolwine BJ, Nemeroff CB, Berns GS, Miller AH. Anterior cingulate activation and error processing during interferon-alpha treatment. Biol Psychiatry 2005; 58: 190-196 [PMID: 16084839]
143. Marsland AL, Petersen KL, Sathanoori R, Muldoon MF, Neumann SA, Ryan C, Flory JD, Manuck SB. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom Med 2006; 68: 895-903 [PMID: 17132839]
144. van der Poorten D, Shahidi M, Tay E, Sesha J, Tran K, McLeod D, Milliken JS, Ho V, Hebbard LW, Douglas MW, George J. Hepatitis C virus induces the cannabinoid receptor 1. PLoS One 2010; 5: [PMID: 20862263 DOI: 10.1371/journal.pone.0012841]
145. Coppola N, Zampino R, Bellini G, Macera M, Marrone A, Pisaturo M, Boemio A, Nobili B, Pasquale G, Maione S, Adinolfi LE, Perrone L, Sagnelli E, Miraglia Del Giudice E, Rossi F. Association between a polymorphism in cannabinoid receptor 2 and severe necroinflammation in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2014; 12: 334-340 [PMID: 23707465 DOI: 10.1016/j.cgh.2013.05.008]
146. Spiegel BM, Younossi ZM, Hays RD, Revicki D, Robbins S, Kanwal F. Impact of hepatitis C on health related quality of life: a systematic review and quantitative assessment. Hepatology 2005; 41: 790-800 [PMID: 15791608]
147. Foster GR. Quality of life considerations for patients with chronic hepatitis C. J Viral Hepat 2009; 16: 605-611 [PMID: 19674284 DOI: 10.1111/j.1365-2893.2009.01154.x]
148. Bernstein D, Kleinman L, Barker CM, Revicki DA, Green J. Relationship of health-related quality of life to treatment adherence and sustained response in chronic hepatitis C patients. Hepatology 2002; 35: 704-708 [PMID: 11870387]
149. Sarkar S, Jiang Z, Evon DM, Wahed AS, Hoofnagle JH. Fatigue before, during and after antiviral therapy of chronic hepatitis C: results from the Virahep-C study. J Hepatol 2012; 57: 946-952 [PMID: 22760009 DOI: 10.1016/j.jhep.2012.06.030]
150. Thein HH, Maruff P, Krahn MD, Kaldor JM, Koorey DJ, Brew BJ, Dore GJ. Improved cognitive function as a consequence of hepatitis C virus treatment. HIV Med 2007; 8: 520-528 [PMID: 17944685]
151. Byrnes V, Miller A, Lowry D, Hill E, Weinstein C, Alsop D, Lenkinski R, Afdhal NH. Effects of anti-viral therapy and HCV clearance on cerebral metabolism and cognition. J Hepatol 2012; 56: 549-556 [PMID: 22027578 DOI: 10.1016/j.jhep.2011.09.015]
152. Adinolfi LE, Utili R, Zampino R, Ragone E, Mormone G, Ruggiero G. Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia. Eur J Gastroenterol Hepatol 1997; 9: 1067-1072 [PMID: 9431896]
153. Buccoliero R, Gambelli S, Sicurelli F, Malandrini A, Palmeri S, De Santis M, Stromillo ML, De Stefano N, Sperduto A, Musumeci SA, Federico A. Leukoencephalopathy as a rare complication of hepatitis C infection. Neurol Sci 2006; 27: 360-363 [PMID: 17122948]